Key result
Surgical non-laser lead extraction is linked to ~99% clinical success, edging out cardiologists with similar safety.
Why the study?
As implantation of cardiac implantable devices rises, the expanding indications for transvenous lead extraction require evaluation of outcomes based on operator profession.
Does operator profession (cardiac surgeon vs cardiologist) affect outcomes and safety in patients undergoing non-laser transvenous lead extraction?
Cohort (n=2,205)
Yes
Does operator profession (cardiac surgeon vs cardiologist) affect outcomes and safety in patients undergoing non-laser transvenous lead extraction?
Non-laser transvenous lead extraction can be performed safely and effectively by both cardiologists and cardiac surgeons, with surgeons achieving slightly higher procedural success rates.
Answers are grounded in this paper and cite their sources.
Supports safe performance by both specialties; leaves open whether operator profession independently affects success in broader populations.
Funding Acknowledgements Type of funding sources: None. OnBehalf PROMET group Background As implantation of cardiac implantable devices (CIED) rises globally, there is a paralleled need for extraction of these devices. Indications for transvenous lead extraction (TLE) is expanding, fuelling demand. This lifesaving procedure is performed by cardiologists and cardiac surgeons (CS). Cardiologists are familiar with transvenous methods whilst cardiac surgeons possess the skillset to address the significant complications associated with this procedure. We compared non-laser TLE outcomes performed by cardiologists and cardiac surgeons from six high-volume extraction centres across Europe. Methods Data was collected retrospectively from six major European TLE centres of 2205 patients and 3849 leads (PROMET). Propensity 1:1 score matching (PSM) was performed to account for confounding variables. PSM model with variables: lead dwell time, infection indication, biventricular system and defibrillator device, was best matched. This dataset was analysed to compare outcomes of TLE performed by the cardiologists and CS. Predictors of 30-day mortality and complications were identified using a multivariate regression analysis. Results Patients treated by CS and cardiologists were similar in age (64.7 vs 66.7 years, p = NS) and equally male (70.3% vs 72.3%, p = 0.39) with a parallel infectious indication (51.7% vs 47.6%, p = 0.1). Surgeons achieved a significantly higher proportion of clinical success than cardiologists (98.9% vs 96.4%, p = 0.001) and complete lead extraction (98% vs 95.9%, p < 0.01) with a higher rate of minor complications (4.1% vs 2.2%, p = 0.024); major complications were similar (0.9% vs 1.2%, respectively, p = 0.46) as was 30-day mortality (3.2% vs 2%, respectively, p = 0.28). Multivariate regression analysis revealed systemic infection (p < 0.001, OR 7.2 [CI 2.3-20.1]) and defibrillator system extraction (p = 0.025, OR 3.4 [CI 1.2-10.2]) increased the odds of 30-day mortality, whilst Evolution™ sheath use reduced the odds (p = 0.025, OR 0.34 [CI 0.13-0.88]); lead dwell time (p = 0.02, OR 1.005 [1-1.009] and Evolution™ sheath use (p = 0.023, OR 2.15[1.1-4.15]) increased the odds of complications. Conclusion Cardiac surgeons and cardiologists achieved a high rate of TLE procedural success and with a similar safety profile, replicating standards seen across Europe.
No takes yet. Share an insight, caveat, or question.
Akhtar et al. (2021) conducted a cohort in Cardiac implantable electronic device requiring extraction (n=2,205). Non-laser transvenous lead extraction by cardiac surgeons vs. Non-laser transvenous lead extraction by cardiologists was evaluated on Clinical success (p=0.001). Non-laser transvenous lead extraction by cardiac surgeons achieved higher clinical success than cardiologists, with similar major complications and 30-day mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: